Work

A prospective, single-center, single-arm clinical study of adjuvant toripalimab combined with axitinib in non-clear renal cell carcinoma (nccRCC) patients with high-risk recurrence factors (IUNU-RC-102).

Year: 2025

Type: article

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.5_suppl.tps613

Authors: Guangxiang Liu, Shun Zhang, Haixiang Qin, Changwei Ji, Hongqian Guo

Institutions: Nanjing Drum Tower Hospital, Nanjing University

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4407699753

FWCI:

Cites:

Cited by:

Related to: 10